BDLSFINOVIQ LTD.

About INOVIQ LTD. (BDLSF)

INOVIQ LTD. (BDLSF) is a N/A company whose shares trade over-the-counter on the Pink tier.

BARD1 Life Sciences Ltd (ASX:BD1) is an Australian-based biotechnology company focused on developing and commercialising non-invasive diagnostic tests for early detection of cancer. BARD1's proprietary technology platform is based on novel tumour markers with potential diagnostic and therapeutic applications across multiple cancers. The pipeline includes two development-stage BARD1 autoantibody tests for early detection of lung and ovarian cancers, and a research-stage cancer vaccine under evaluation for treatment of cancer. Additional diagnostic projects are being evaluated for prostate, breast and other cancers. BARD1 is committed to transforming the early detection and prevention of cancer to help improve patients' lives. BARD1 is headquartered in Perth, Australia, and has contract research laboratories at University of Geneva, Switzerland.

BDLSF key facts

Ticker symbol

BDLSF

Market tier

Pink

Country of incorporation

AU

Shares outstanding

79,817,772

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Explore more: Pink stocks · OTC stocks starting with B